Freedom of Information responses from the MHRA - week commencing 1 February 2021
Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 1 February 2021
- From:
- Medicines and Healthcare products Regulatory Agency
- Published
- 24 March 2021
Documents
GDP Inspection Report 1 (FOI-21-003)
PDF, 2.56 MB, 13 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
GDP Inspection Report 2 (FOI-21-003)
PDF, 1.97 MB, 8 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Annex 4 - Specific adverse drug reaction follow up forms (FOI-21-011)
PDF, 650 KB, 11 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Lacosamide Additional Information (FOI-21-011)
PDF, 107 KB, 7 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Pharmacovigilance inspection reports 1 (FOI-21-16)
PDF, 3.08 MB, 38 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Pharmacovigilance inspection reports 2 (FOI-21-16)
PDF, 2.85 MB, 38 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Pharmacovigilance inspection reports 3 (FOI-21-16)
PDF, 311 KB, 18 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Pharmacovigilance inspection reports 4 (FOI-21-16)
PDF, 4.65 MB, 31 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Pharmacovigilance inspection reports 5 (FOI-21-16)
PDF, 3.54 MB, 57 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Pharmacovigilance inspection reports 6 (FOI-21-16)
PDF, 2.71 MB, 12 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Pharmacovigilance inspection reports 7 (FOI-21-16)
PDF, 3.33 MB, 46 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Dioctyl pre-clinical and clinical expert report (FOI-21-026)
PDF, 479 KB, 10 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Application for product licence (FOI-21-066)
PDF, 1.18 MB, 21 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Assessment Report 1 (FOI-21-069)
PDF, 1.18 MB, 21 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Assessment Report 2 (FOI-21-069)
PDF, 929 KB, 15 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Details
See the MHRA FOI disclosure log.
See all FOI responses from the MHRA for 2021.